Functional Proteomic Profiling of Triple-Negative Breast Cancer
Open Access
Abstract
Triple-negative breast cancer (TNBC) is a subtype of breast cancer that comprises various disease entities, all of which share a set of common features: a lack of expression of the estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2, respectively. Because of their receptor status, conventional chemotherapy remains the main therapeutic option for TNBC patients. We employed a reverse phase protein array approach (RPPA), complemented by immunohistochemistry, to quantitatively profile the activation state of 84 actionable key signaling intermediates and phosphoproteins in a set of 44 TNBC samples. We performed supervised and unsupervised approaches to proteomic data analysis to identify groups of samples sharing common characteristics that could be amenable to existing therapies. We found the heterogenous activation of multiple pathways, with PI3 K/AKT/mTOR signaling being the most common event. Some specific individualized therapeutic possibilities include the expression of oncogenic KIT in association with cytokeratin 15 and Erk1/2 positive tumors, both of which may have clinical value.Keywords
Funding Information
- A Race against Breast Cancer foundation (n/a)
This publication has 47 references indexed in Scilit:
- Proteomic Profiling of Triple-negative Breast Carcinomas in Combination With a Three-tier Orthogonal Technology Approach Identifies Mage-A4 as Potential Therapeutic Target in Estrogen Receptor Negative Breast CancerMolecular & Cellular Proteomics, 2013
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- EZH2 Promotes Expansion of Breast Tumor Initiating Cells through Activation of RAF1-β-Catenin SignalingCancer Cell, 2011
- Tissue proteomics of the human mammary gland: Towards an abridged definition of the molecular phenotypes underlying epithelial normalcyMolecular Oncology, 2010
- Molecular classification of solid tumours: towards pathway-driven therapeuticsBritish Journal of Cancer, 2009
- Triple-Negative Breast Cancer: Risk Factors to Potential TargetsClinical Cancer Research, 2008
- A single lysis solution for the analysis of tissue samples by different proteomic technologiesMolecular Oncology, 2008
- An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast CancerCancer Research, 2008
- Evidence for a stem cell hierarchy in the adult human breastJournal of Cell Biology, 2007
- [9] TM4 Microarray Software Suite2006